Literature DB >> 30783882

Stiff Person Syndrome and Type 1 Diabetes Mellitus: a Case of the Chicken or the Egg?

John Tyler Rathbun1, Jacob Imber2.   

Abstract

Anti-glutamic acid decarboxylase (anti-GAD) antibodies are linked with both autoimmune diabetes and the rare neurological disorder stiff person syndrome (SPS). SPS is an uncommon autoimmune-mediated condition characterized by painful episodic spasms and progressive muscle rigidity. We present the case of a 23-year-old non-diabetic, insulin-naïve woman with known SPS who was hospitalized for SPS-related symptomatology. The patient quickly developed type 1 diabetes mellitus (T1DM) with unexpectedly large insulin requirements. To our knowledge, there are no other reports describing rapid T1DM development during an acute hospitalization for SPS and fewer than 5 case reports describing the association of SPS with extreme insulin resistance. Our case highlights the key clinical features, pathology, and pathogenesis of both SPS and T1DM and explores the relationship between the two disease processes.

Entities:  

Keywords:  anti-glutamic acid decarboxylase (anti-GAD) antibodies; stiff person syndrome; type 1 diabetes mellitus

Year:  2019        PMID: 30783882      PMCID: PMC6544725          DOI: 10.1007/s11606-019-04835-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  33 in total

1.  The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome.

Authors:  M C Dalakas; M Fujii; M Li; B McElroy
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

2.  Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome); report of a case and some observations in 13 other cases.

Authors:  F P MOERSCH; H W WOLTMAN
Journal:  Proc Staff Meet Mayo Clin       Date:  1956-07-25

3.  The role of C-peptide levels in screening for latent autoimmune diabetes in adults.

Authors:  David S H Bell; Fernando Ovalle
Journal:  Am J Ther       Date:  2004 Jul-Aug       Impact factor: 2.688

Review 4.  Sudden death and paroxysmal autonomic dysfunction in stiff-man syndrome.

Authors:  H Mitsumoto; M J Schwartzman; M L Estes; S M Chou; E F La Franchise; P De Camilli; M Solimena
Journal:  J Neurol       Date:  1991-04       Impact factor: 4.849

5.  Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.

Authors:  Raghavanpillai Raju; Jefferson Foote; J Paul Banga; Tyler R Hall; Carolyn J Padoa; Marinos C Dalakas; Eva Ortqvist; Christiane S Hampe
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

6.  Brain gamma-aminobutyric acid changes in stiff-person syndrome.

Authors:  Lucien M Levy; Igor Levy-Reis; Mavis Fujii; Marinos C Dalakas
Journal:  Arch Neurol       Date:  2005-06

7.  Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.

Authors:  T Lohmann; M Hawa; R D Leslie; R Lane; J Picard; M Londei
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

Review 8.  Stiff man syndrome and related conditions.

Authors:  Hans-Michael Meinck; Philip D Thompson
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

9.  A woman with the stiff-man syndrome.

Authors:  R ASHER
Journal:  Br Med J       Date:  1958-02-01

10.  Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.

Authors:  Goran Rakocevic; Raghavanpillai Raju; Marinos C Dalakas
Journal:  Arch Neurol       Date:  2004-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.